Documentos relacionados

1. Clinicopathological characteristics of myelodysplastic syndromes with del(5q) in Taiwan.
2. Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms.
3. [How Myelodysplastic Syndrome is Diagnosed].
4. Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes.
5. Diagnosis and classification of myelodysplastic syndromes.
6. Shallow whole-genome sequencing of bone marrow aspirates in myelodysplastic neoplasms: A retrospective comparison with cytogenetics.
7. Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
8. Dysregulation of immune cell and cytokine signalling correlates with clinical outcomes in myelodysplastic syndrome (MDS).
9. Clonality in context: hematopoietic clones in their marrow environment.
10. Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation.